LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025

Article content

LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025

Article content

Vancouver, June 20, 2025 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) announces results for the fiscal period ending April 30, 2025. All references to dollar amounts in this release are in Canadian dollars.

Article content

Article content

Highlights During and After the Quarter

Article content

During the three months ended April 30, 2025:

Article content

•        On February 9, 2025, the Company provided an update on a Rapid Development Plan (“RDP”) for Norra Kärr, to be in production in the shortest possible timeframe, supplying HREE-rich eudialyte concentrate and industrial mineral nepheline syenite.

Article content

Article content

•        The Company provided an update on the value creation options being considered for Woxna Graphite, on February 16, 2025, including a possible restart of operations, the production of high-quality flake graphite concentrate.         

Article content

Article content

•        On March 23, 2025, the Company provided a progress update on Norra Kärr, in the context of the European Commission’s (“EC”) Joint White Paper for European Readiness 2030, highlighting the increasing geopolitical competition over critical raw materials (“CRMs”) and the need for the EU and its member states to build strategic reserves of raw materials.

Article content

•        On March 25, 2025, the EU announced its first list of Strategic Projects under the Critical Raw Materials Act (“CRMA”); Norra Kärr was not included. The Company stated its plan to reapply in the next round of applications.

Article content

•        On April 23, 2025, the Company announced granting of stock options (the “Options”) to directors, officers and consultants of the Company to purchase an aggregate of 6,850,000 common shares (the “Optioned Shares”) of the Company, at exercise price of C$0.24 per Optioned Share, expiring on the date that is 5 years from the date of grant for directors and officers and three years from the date of grant for consultants. The Options will vest 33% on the date of the grant, 33% one year after the date of grant and 34% two years after the date of grant. The Options were issued pursuant to the terms of the Company’s Option Plan.

Article content

Article content

Results of Operations

Article content

Three Months Ended April 30, 2025, Compared to Three Months Ended January 31, 2025

Article content

During the three months ended April 30, 2025 (“Q2 2025”) the Company reported a net loss of $1,179,168 compared to a reported net loss of $669,216 for the three months ended January 31, 2025 (“Q1 2025”), an increase in loss by $509,952, the increase in loss mainly due to share based compensation expenses of $585,529 (Q1 2025 – $129,292) and foreign exchange loss of $117,063 (Q1 2025 – gain $1,690).

Article content

Three Months Ended April 30, 2025, Compared to Three Months Ended April 30, 2024

Article content

During the three months ended April 30, 2025 (“2025 period”), the Company reported a net loss of $1,179,168 compared to a net loss of $859,529 for the three months ended April 30, 2024 (“2024 period”), an increase in loss of $319,639, the increase in loss mainly due to share based compensation expenses of $585,529 (Q2 2024 – $349,923) and foreign exchange loss of $117,063 (Q2 2024 – $5,754).

Article content

Selected Financial Data

Article content

The following selected financial information is derived from the unaudited condensed consolidated interim financial statements of the Company prepared in accordance with IFRS.